Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Living Well on Androgen Deprivation Therapy: A Comprehensive Approach to Prostate Cancer Survivorship

NCT02108613 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT02108613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02108613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Living Well on Androgen Deprivation Therapy: A Comprehensive Approach to Prostate Cancer Survivorship
Lead sponsor
British Columbia Cancer Agency
Phase
Not applicable
Overall status
Withdrawn
Start date
April 30, 2014
Completion date
March 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer